← Back to VBIO

Valion Bio, Inc. - Common stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 14/08/2026Mar 2026Filed 14/08/2026Sep 2025Filed 14/11/2025Jun 2025Filed 14/08/2026Mar 2025Filed 14/08/2026Sep 2024Filed 14/11/2025Jun 2024Filed 14/11/2025Mar 2024Filed 14/11/2025
$0.1$0.1$0.1$0.1$0.1$0.3
−$7.1−$6.2−$2.6−$1.9−$1.5−$1.4−$1.3−$1.5
−$2.17−$2.23−$1.97−$2.19−$2.52−$0.23−$5.37−$17.15
3.42.91.30.90.66.2

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.